| CTRI Number |
CTRI/2024/07/071722 [Registered on: 31/07/2024] Trial Registered Prospectively |
| Last Modified On: |
30/01/2026 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Process of Care Changes |
| Study Design |
Non-randomized, Multiple Arm Trial |
|
Public Title of Study
|
Development of a telestroke network to improve stroke care |
|
Scientific Title of Study
|
Development of a Telestroke Network to improve Stroke Care: A Quasi Experimental Study(TeStNet) |
| Trial Acronym |
TESTNET |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Biman Kanti Ray |
| Designation |
Professor |
| Affiliation |
BIN, IPGMER, Kolkata |
| Address |
Department of Neuromedicine,
2nd floor,
Bangur Institute of neurosciences New Block,
52/1a, Sambhunath Pandit St, Gokhel Road, Bhowanipore
Kolkata WEST BENGAL 700020 India |
| Phone |
9433185327 |
| Fax |
|
| Email |
bimankantiproject@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Biman Kanti Ray |
| Designation |
Professor |
| Affiliation |
BIN, IPGMER, Kolkata |
| Address |
Department of Neuromedicine,
2nd floor,
Bangur Institute of Neurosciences New Block,
52/1a, Sambhunath Pandit St, Gokhel Road, Bhowanipore
WEST BENGAL 700020 India |
| Phone |
9433185327 |
| Fax |
|
| Email |
bimankantiproject@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Biman Kanti Ray |
| Designation |
Professor |
| Affiliation |
BIN, IPGMER, Kolkata |
| Address |
Department of Neuromedicine,
2nd floor,
Bangur Institute of Neurosciences New Block,
52/1a, Sambhunath Pandit St, Gokhel Road, Bhowanipore
WEST BENGAL 700020 India |
| Phone |
9433185327 |
| Fax |
|
| Email |
bimankantiproject@gmail.com |
|
|
Source of Monetary or Material Support
|
| Institute of Postgraduate Medical Education and Research, Kolkata and ICMR, New Delhi |
|
|
Primary Sponsor
|
| Name |
INDIAN COUNCIL OF MEDICAL RESEARCH |
| Address |
Ansari Nagar, New Delhi - 110029, India |
| Type of Sponsor |
Government funding agency |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 9 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Barun Das |
Alipurduar District Hospital |
Department of General Medicine, Hospital Rd, Ward no. 13, P.O. Alipurduar, PIN- 736121 Jalpaiguri WEST BENGAL |
9831878735
drbarundas79@gmail.com |
| Dr Amit Das |
Basirhat Superspeciality Hospital |
Department of General Medicine, Basirhat, PIN- 743412 North Twentyfour Parganas WEST BENGAL |
9836372694
amit_das2904@rediffmail.com |
| Dr Dipanjan Das |
Bishnupur Superspeciality Hospital |
Department of General Medicine, Ahalla Bai Road, Krishna Ganj, Bishnupur, PIN- 722122 Bankura WEST BENGAL |
8902051838
dipanjan.das87@gmail.com |
| Dr Sanat Kumar Jatua |
Diamond Harbour Government Medical College and Hospital |
Department of General Medicine, Haridanga, Newtown, Diamond Harbour, PIN- 743331 South Twentyfour Parganas WEST BENGAL |
9830450225
drskjatua@gmail.com |
| Dr Amitava Kundu |
Islampur Superspeciality Hospital |
Department of General Medicine, Sukanto Pally, PIN- 733202
Uttar Dinajpur WEST BENGAL |
8250435706
dramtabhakundu@gmail.com |
| Dr Sk Mohammad Yousuf |
Jangipur Superspeciality Hospital |
Department of General Medicine, RAGHUNATHGANJ, PIN- 742225
Murshidabad WEST BENGAL |
9083557450
dr.skyousuf@gmail.com |
| Dr Snehasis Das |
Jhargram Government and Hospital |
Department of General Medicine, Vidyasagar Pally, Jhargram, PIN- 721507 Medinipur WEST BENGAL |
9433254978
snehasisds@gmail.com |
| Dr Keshab Sinharay |
Prafulla Chandra Sen Government Medical College and Hospital |
Arambagh, PIN- 712601 Hugli WEST BENGAL |
9433013147
keshabsinharay@gmail.com |
| Dr Samir Kanta Datta |
Suri Superspeciality Hospital |
Departement of General Medicine, Suri Sadar Hospital Road, Sabuj Pally, Suri, PIN- 731101 Birbhum WEST BENGAL |
9933713506
samirkantadatta@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| IPGME&R Research Oversite Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: I61||Nontraumatic intracerebral hemorrhage, (2) ICD-10 Condition: I63||Cerebral infarction, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Comprehensive Telestroke Model |
Hospitals in group A will have telemedicine service in Hub-Spoke-Subspoke model and community awareness activities will be carried out in the district where these hospitals are situated. These hospitals will be connected to the sub centres and health & wellness centres of their district via telemedicine. Duration will be 1 year. |
| Comparator Agent |
Control |
Hospitals in group C will have no telemedicine service and no community awareness activity. Duration will be 1 year. |
| Comparator Agent |
Conventional telestroke model |
Hospitals in group B will have telemedicine service in Hub-and-spoke model. No community awareness activity will be conducted in the districts where these hospitals are situated. Duration will be 1 year. |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
90.00 Year(s) |
| Gender |
Both |
| Details |
• Aged 18 years & above.
• Resident of the study area.
|
|
| ExclusionCriteria |
| Details |
1. Do not give consent for the study.
2. Resident of a district other than that of the study hospital.
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Proportion of stroke patients achieving MRS 0 to 2 at 90 days from onset of stroke. |
90 days |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Proportion of stroke patient arriving within 4.5 hours |
4.5 hours |
| Onset-to-door time |
7 days |
| Onset-to-needle time in thrombolysed patients |
4.5 hours |
| Percentage of ischemic stroke patients thrombolysed |
1 day |
| MRS at discharge |
7 days |
| Treatment outcome |
90 days |
|
|
Target Sample Size
|
Total Sample Size="1350" Sample Size from India="1350"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 4 |
|
Date of First Enrollment (India)
|
15/08/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Open to Recruitment |
| Recruitment Status of Trial (India) |
Open to Recruitment |
Publication Details
Modification(s)
|
• Ray BK, Dutta A, Sarkar A, Podder G, Dutta D, Biswas A. “Protocol for the development of a comprehensive telestroke network to improve stroke care in developing countries: The TeStNet trial.” Int J Non Commun Dis: 2025; 10:41-7. |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
India is a country where majority of the population live in the rural areas where evidence based stroke care is lacking as most of the neurologists, stroke specialists, and stroke-ready hospitals are located in major cities far from the reach of the rural population. Stroke awareness is lacking amongst many people resulting in unnecessary delay in seeking proper medical attention and timely presentation to a stroke-ready hospital. Telemedicine can be utilised to provide expert guidance to remote hospitals which are within the reach of the rural population. Availability of stroke experts via telemedicine can convert these hospitals to stroke-ready hospitals and improve the overall stroke care. Telemedicine can also be utilised to connect the community level health workerswith the stroke experts to raise stroke-related awareness and reduce prehospital delay. In this study our aim is to explore the efficacy of telemedicine in reducing stroke-related morbidity and mortality in hospitals connected to a neurology facility in comparison with similar hospitals lacking telemedicine facility. We also want to study the efficacy of telemedicine in the reduction of prehospital delayby connecting community level health workers with stroke experts. In this quasi-experimental study we will evaluate and compare the efficacy of two intervention models, namely ‘Comprehensive Telestroke model’ which not only provides telemedicine support to a remote hospital but also raises community awareness to reduce prehospital delay, and ‘Conventional Telestroke model’ which provides telemedicine support only but does not address the community awareness component. |